Advertisement

Canadian Journal of Public Health

, Volume 92, Issue 4, pp 250–254 | Cite as

Trends of Hepatitis B and Hepatitis C Mortality in Canada, 1979–1997

  • Gina Pohani
  • Shimian ZouEmail author
Article

Abstract

Mortality data from Statistics Canada were analyzed to measure the temporal trends and burden of illness attributed to viral hepatitis in Canada. Analysis of age-standardized mortality rates from 1979 to 1997 showed an increasing trend in mortality for both hepatitis B and non-A, non-B hepatitis (NANBH), most of which are attributed to hepatitis C infections. Hepatitis B and NANBH agestandardized mortality rates increased respectively, from 0.03 and 0.12 deaths per 100,000 population in 1979 to 0.26 and 0.41 deaths per 100,000 in 1997. Male mortality rates were consistently higher than female for both diseases. Among deaths from chronic liver disease, over 1,000 deaths were estimated to have been caused by hepatitis B and hepatitis C annually. Although the hepatitis B or NANBH recorded deaths largely underestimate the true burden of HBV and HCV in Canada, the temporal trends are useful as they reflect changes in the impact of both diseases.

Résumé

Nous avons analysé les données de Statistique Canada sur la mortalité pour mesurer les tendances temporelles des maladies attribuées à l’hépatite virale au Canada. L’analyse des taux comparatifs de mortalité, de 1979 à 1997, montre une tendance croissante de la mortalité à la fois dans les cas d’hépatite B et dans les cas d’hépatite non A–non B (NANB), dont la plupart sont attribués à l’hépatite C. Les taux comparatifs de mortalité causée par l’hépatite B et l’hépatite NANB ont augmenté, passant respectivement de 0,03 et 0,12 décès pour 100 000 habitants en 1979, à 0,26 et à 0,41 décès pour 100 000 habitants en 1997. Les taux de mortalité chez les hommes étaient constamment plus élevés que chez les femmes, qu’il s’agisse de l’hépatite B ou de l’hépatite NANB. On estime que, sur le nombre total des décès causés par une maladie chronique du foie, plus de 1 000 décès par année sont causés par l’hépatite B et l’hépatite C. Bien que le nombre de décès attribués à l’hépatite B ou à l’hépatite NANB soit bien en deçà du fardeau réel de l’HVB et de l’HVC au Canada, les tendances temporelles sont utiles, car elle reflètent les changements dans l’incidence de ces deux maladies.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Edmunds WJ, Medley GF, Nokes DJ, et al. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect 1996;117(2):313–325.CrossRefGoogle Scholar
  2. 2.
    World Health Organization. World Health Report: Life in the 21st Century: A Vision for All. Geneva: WHO, 1998.Google Scholar
  3. 3.
    Hadler SC, Margolis H. Hepatitis B immunization: Vaccine types, efficacy, and indications for immunization. Current Clinical Topics In Infectious Diseases 1992;12:282–308.PubMedGoogle Scholar
  4. 4.
    Tepper ML, Gully P. Hepatitis B. CMAJ 1997;156:1033.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Remis RS, Hogg R, Krahn MD, et al. Estimating the number of blood transfusion recipients infected with hepatitis C in Canada 1960–85 and 1990–92. Report to Health Canada, June 22, 1998.Google Scholar
  6. 6.
    Zou S, Tepper M, El Saadany S. Prediction of hepatitis C burden in Canada. Can J Gastroenterol 2000;14(7):575–80.CrossRefGoogle Scholar
  7. 7.
    Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepatitis 1999;6:35–47.CrossRefGoogle Scholar
  8. 8.
    Maddrey WC. Hepatitis B: An important public health issue. J Med Virology 2000;61(3):362–66.CrossRefGoogle Scholar
  9. 9.
    Chin J (Ed.). Control of Communicable Diseases Manual, 17th ed. Washington, DC: American Public Health Association, 2000.Google Scholar
  10. 10.
    MMWR. Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease. 1998;47(RR-19):1–36.Google Scholar
  11. 11.
    Alter MJ. The epidemiology of acute and chronic hepatitis C. Clin Liver Disease 1997;1:559–68.CrossRefGoogle Scholar
  12. 12.
    Statistics Canada. Causes of Death. Ottawa: Health Statistics Division, 1979–1996.Google Scholar
  13. 13.
    World Health Organization. International Classification of Diseases, Ninth revision, 1977.Google Scholar
  14. 14.
    Myers KA, Farquhar D. Improving the Accuracy of Death Certification. CMAJ 1998;159(10):1317–23.Google Scholar
  15. 15.
    http://www.cehip.org/DataArea/New%20Folder/mortality.htm. Accessed 06/08/2000.
  16. 16.
    Statistics Canada. 1991 Census of Canada. Ottawa.Google Scholar
  17. 17.
    Dana F, Becherer PR, Bacon BR. Hepatitis C virus, What recent studies can tell us. Postgraduate Medicine 1994;95:121–30.CrossRefGoogle Scholar
  18. 18.
    Hollinger FB, Dienstag JL. Hepatitis Viruses. In: Manual of Clinical Microbiology. Washington, DC: American Society for Microbiology, 1985;813–823.Google Scholar
  19. 19.
    National Notifiable Disease Reporting System. Laboratory Centre for Disease Control. Health Canada, 1999.Google Scholar
  20. 20.
    Alter MJ, Shapiro CN, Coleman PJ, Margolis HS. Viral Hepatitis in North America. In: Nishioka K, Viral Hepatitis and Liver Disease. Tokyo, New York: Springer-Verlag, 1994;439–443.CrossRefGoogle Scholar
  21. 21.
    Margolis HS, Alter MJ, Hadler SC, et al. Hepatitis B: Evolving epidemiology and implications for control. Semin Liver Dis 1991;11:84–92.CrossRefGoogle Scholar
  22. 22.
    Statistics Canada. Immigrant Population, by Place of Birth Showing Periods of Immigration, 1996 Census. CANSIM Utility. Ottawa: Statistics Canada, 1996–1997.Google Scholar
  23. 23.
    Statistics Canada. Immigrant Population, by Place of Birth, 1996 Census. CANSIM Utility. Ottawa: Statistics Canada, 1996–1997.Google Scholar
  24. 24.
    Alter MJ. Epidemiology of hepatitis C in the west. Semin Liver Dis 1995;15(1):5–14.CrossRefGoogle Scholar
  25. 25.
    Colquhoun SD. Hepatitis C: A clinical update. Arch Surg 1996;131:18–23.CrossRefGoogle Scholar
  26. 26.
    Zou S, Tepper M, Giulivi A. Current status of hepatitis C in Canada. Can J Public Health 2000(suppl 1):S10–S15.Google Scholar
  27. 27.
    Zou S, Zhang J, Tepper M, et al. Enhanced surveillance of acute hepatitis B and acute hepatitis C in four health regions in Canada. Can J Infect Dis 2001 (In press).Google Scholar

Copyright information

© The Canadian Public Health Association 2001

Authors and Affiliations

  1. 1.Blood-Borne Pathogens Division, Bureau of Infectious DiseasesCentre for Infectious Disease Prevention and Control, Population and Public Health Branch, Health CanadaOttawaCanada

Personalised recommendations